Halper Sadeh LLC Encourages CDTX, MRSN, HOLX Shareholders to Contact the Firm to Discuss Their Rights
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 14 2025
0mins
Should l Buy HOLX?
Source: PRnewswire
Investigation of Companies: Halper Sadeh LLC is investigating Cidara Therapeutics, Mersana Therapeutics, and Hologic for potential violations of federal securities laws and breaches of fiduciary duties related to their sales to other companies.
Shareholder Rights: Shareholders of the mentioned companies are encouraged to contact Halper Sadeh LLC to learn about their rights and options, as there may be limited time to enforce these rights.
Proposed Transactions: Cidara shareholders may receive $221.50 per share, Mersana shareholders could receive up to $55.25 per share, and Hologic shareholders are set to receive $76.00 per share plus potential additional payments.
Legal Representation: Halper Sadeh LLC offers to handle cases on a contingent fee basis, meaning shareholders would not incur out-of-pocket legal fees, and the firm has a history of representing investors in securities fraud cases.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HOLX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HOLX
Wall Street analysts forecast HOLX stock price to rise
12 Analyst Rating
0 Buy
12 Hold
0 Sell
Hold
Current: 76.010
Low
76.00
Averages
77.56
High
79.00
Current: 76.010
Low
76.00
Averages
77.56
High
79.00
About HOLX
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Apple Shares Drop Nearly 4% Amid Engineering Setbacks for Foldable iPhone
- Apple Stock Decline: Apple's shares fell nearly 4% on Tuesday, leading the S&P 500 lower, after Nikkei Asia reported setbacks in the engineering test phase for its planned foldable iPhone, which could adversely affect mass production and product shipments.
- Universal Music Group Surge: Shares of Universal Music Group surged almost 13% after hedge fund investor Bill Ackman's Pershing Square Capital Management offered to acquire the company in a cash and stock deal valued at approximately €55.8 billion ($64.4 billion), significantly boosting market expectations for its future.
- Arm Holdings Downgrade: Arm Holdings' stock dropped over 4% following Morgan Stanley's downgrade from overweight to equal weight, citing that the company's strategic pivot to chips amid the AI boom will take time, and near-term risks like rising R&D costs and DRAM shortages could weigh on the stock.
- Healthcare Stocks Bounce Back: Healthcare stocks rallied as the Center for Medicare & Medicaid Services finalized a payment increase for privately run Medicare Advantage plans, exceeding its initial proposal from January, with UnitedHealth jumping 10% and Humana and CVS Health rising 8% and 7%, respectively.
See More
Hologic Acquired by Blackstone and TPG Funds
- Acquisition Announcement: Hologic has announced its acquisition by funds managed by Blackstone and TPG, marking a significant consolidation in the medical device sector that is expected to enhance its market competitiveness.
- Funding Background: The acquisition is led by two prominent investment firms, with Blackstone and TPG's experience in the healthcare industry likely to provide strategic support for Hologic's future growth.
- Market Reaction: The market has reacted positively to the acquisition news, with Hologic's stock price expected to rise due to anticipated synergies, boosting investor confidence.
- Strategic Implications: This acquisition is poised to not only expand Hologic's market share but also potentially drive further investments in innovative medical technologies, enhancing the company's long-term growth potential.
See More
Hologic Completes Acquisition, Appoints New CEO
- Acquisition Completed: Hologic, Inc. has completed its acquisition by funds managed by Blackstone and TPG, valued at up to $79 per share, marking its transition to a private company and expected to enhance its innovation capabilities in women's health.
- CEO Appointment: Joe Almeida has been appointed as CEO, effective immediately, bringing extensive experience in medical technology that will provide new strategic direction and strengthen Hologic's leadership in global women's health.
- Shareholder Returns: Hologic shareholders will receive $76 per share in cash plus a non-tradable contingent value right (CVR) worth up to $3, with total returns potentially reaching $79 per share, designed to incentivize the company to achieve revenue targets over the next two years.
- Market Impact: This acquisition and the establishment of a new leadership team are expected to drive further development in medical technology for Hologic, enhancing its market competitiveness while attracting more investment to support innovation and business expansion.
See More
HOLOGIC INC NAMES JOSÉ (JOE) E. ALMEIDA AS NEW CEO, EFFECTIVE IMMEDIATELY
- New Appointment: José (Joe) E. Almeida has been appointed as the Chief Executive Officer of Hologic Inc.
- Immediate Effect: The appointment of Almeida takes effect immediately.
See More
BLACKSTONE AND TPG FINALIZE HOLOGIC ACQUISITION
- Acquisition Announcement: Blackstone and TPG have completed the acquisition of a company named Hologic.
- Strategic Implications: This acquisition is expected to enhance their portfolio and strengthen their position in the healthcare sector.
See More
Broadcom Partners with Google for AI Chip Supply Agreement
- AI Chip Supply Agreement: Broadcom has entered into an agreement to supply AI chips to Google and signed an expanded deal with Anthropic to provide approximately 3.5 gigawatts of computing capacity, which is expected to significantly enhance Google's competitive edge in the AI sector.
- Stock Price Reaction: Broadcom shares rose by 3%, while Alphabet's shares increased slightly by 0.2%, reflecting the market's positive outlook on the collaboration and its potential to drive future technological innovations and market share growth.
- S&P 500 Component Change: Casey's General Stores will replace Hologic in the S&P 500 prior to Thursday's open, with Casey's shares rising about 1%, while Hologic's shares were halted due to the completion of its acquisition by Blackstone and TPG Global, indicating increased market confidence in Casey's.
- Medicare Payment Increase: Healthcare stocks surged as the Center for Medicare & Medicaid Services finalized a payment increase for privately run Medicare Advantage plans, with Humana's shares soaring nearly 10%, UnitedHealth rising 6%, and CVS Health advancing nearly 7%, signaling optimistic sentiment towards the healthcare insurance sector.
See More
Apple Shares Drop Nearly 4% Amid Engineering Setbacks for Foldable iPhone
- Apple Stock Decline: Apple's shares fell nearly 4% on Tuesday, leading the S&P 500 lower, after Nikkei Asia reported setbacks in the engineering test phase for its planned foldable iPhone, which could adversely affect mass production and product shipments.
- Universal Music Group Surge: Shares of Universal Music Group surged almost 13% after hedge fund investor Bill Ackman's Pershing Square Capital Management offered to acquire the company in a cash and stock deal valued at approximately €55.8 billion ($64.4 billion), significantly boosting market expectations for its future.
- Arm Holdings Downgrade: Arm Holdings' stock dropped over 4% following Morgan Stanley's downgrade from overweight to equal weight, citing that the company's strategic pivot to chips amid the AI boom will take time, and near-term risks like rising R&D costs and DRAM shortages could weigh on the stock.
- Healthcare Stocks Bounce Back: Healthcare stocks rallied as the Center for Medicare & Medicaid Services finalized a payment increase for privately run Medicare Advantage plans, exceeding its initial proposal from January, with UnitedHealth jumping 10% and Humana and CVS Health rising 8% and 7%, respectively.
See More
Hologic Acquired by Blackstone and TPG Funds
- Acquisition Announcement: Hologic has announced its acquisition by funds managed by Blackstone and TPG, marking a significant consolidation in the medical device sector that is expected to enhance its market competitiveness.
- Funding Background: The acquisition is led by two prominent investment firms, with Blackstone and TPG's experience in the healthcare industry likely to provide strategic support for Hologic's future growth.
- Market Reaction: The market has reacted positively to the acquisition news, with Hologic's stock price expected to rise due to anticipated synergies, boosting investor confidence.
- Strategic Implications: This acquisition is poised to not only expand Hologic's market share but also potentially drive further investments in innovative medical technologies, enhancing the company's long-term growth potential.
See More
Hologic Completes Acquisition, Appoints New CEO
- Acquisition Completed: Hologic, Inc. has completed its acquisition by funds managed by Blackstone and TPG, valued at up to $79 per share, marking its transition to a private company and expected to enhance its innovation capabilities in women's health.
- CEO Appointment: Joe Almeida has been appointed as CEO, effective immediately, bringing extensive experience in medical technology that will provide new strategic direction and strengthen Hologic's leadership in global women's health.
- Shareholder Returns: Hologic shareholders will receive $76 per share in cash plus a non-tradable contingent value right (CVR) worth up to $3, with total returns potentially reaching $79 per share, designed to incentivize the company to achieve revenue targets over the next two years.
- Market Impact: This acquisition and the establishment of a new leadership team are expected to drive further development in medical technology for Hologic, enhancing its market competitiveness while attracting more investment to support innovation and business expansion.
See More
HOLOGIC INC NAMES JOSÉ (JOE) E. ALMEIDA AS NEW CEO, EFFECTIVE IMMEDIATELY
- New Appointment: José (Joe) E. Almeida has been appointed as the Chief Executive Officer of Hologic Inc.
- Immediate Effect: The appointment of Almeida takes effect immediately.
See More
BLACKSTONE AND TPG FINALIZE HOLOGIC ACQUISITION
- Acquisition Announcement: Blackstone and TPG have completed the acquisition of a company named Hologic.
- Strategic Implications: This acquisition is expected to enhance their portfolio and strengthen their position in the healthcare sector.
See More
Broadcom Partners with Google for AI Chip Supply Agreement
- AI Chip Supply Agreement: Broadcom has entered into an agreement to supply AI chips to Google and signed an expanded deal with Anthropic to provide approximately 3.5 gigawatts of computing capacity, which is expected to significantly enhance Google's competitive edge in the AI sector.
- Stock Price Reaction: Broadcom shares rose by 3%, while Alphabet's shares increased slightly by 0.2%, reflecting the market's positive outlook on the collaboration and its potential to drive future technological innovations and market share growth.
- S&P 500 Component Change: Casey's General Stores will replace Hologic in the S&P 500 prior to Thursday's open, with Casey's shares rising about 1%, while Hologic's shares were halted due to the completion of its acquisition by Blackstone and TPG Global, indicating increased market confidence in Casey's.
- Medicare Payment Increase: Healthcare stocks surged as the Center for Medicare & Medicaid Services finalized a payment increase for privately run Medicare Advantage plans, with Humana's shares soaring nearly 10%, UnitedHealth rising 6%, and CVS Health advancing nearly 7%, signaling optimistic sentiment towards the healthcare insurance sector.
See More
